Unlike other epigenetic regulators like the histone methyltransferase MLL1, LSD1 has not been found mutated in AML, but it is highly expressed in leukemic blasts in about 60% of AML patients as well as in other hematological malignancies (14). The gene discussed is PRDM9; the disease is acute myeloid leukemia.